Aziz Sheikh (OBE, FRSE, FMedSci)
Professor of Primary Care Research and Development
- Usher Institute
- College of Medicine and Veterinary Medicine
Contact details
Address
- Street
-
Usher Institute – The University of Edinburgh
Old Medical School
Teviot Place - City
- Edinburgh
- Post code
- EH8 9AG
- Street
-
Usher Institute – The University of Edinburgh
NINE Edinburgh BioQuarter
9 Little France Road - City
- Edinburgh
- Post code
- EH16 4UX
Background
Professor Sir Aziz Sheikh is Director of the Usher Institute. He is also Dean of Data for The University of Edinburgh, Director of the Asthma UK Centre for Applied Research (AUKCAR), Director of the Scottish Allergy and Respiratory Academy (SARA), and Co-Director of the NHS Digital Academy Digital Health Leadership Programme.
Qualifications
BSc, MBBS, MSc, MD, FRCGP, FRCP, FRCPE, FFPH, FACMI, FFCI, FRSE, FMedSci
Responsibilities & affiliations
Currently Aziz holds a number of visiting chairs, namely: University of Birmingham (UK), Queen Mary’s University of London (UK) and Maastricht University (Netherlands). He was previously Visiting Professor of Medicine at Harvard Medical School.
He is an editorial board member of BMC Medicine, Health Informatics Journal, Journal of the Royal Society of Medicine, Medical Care and PLOS Medicine, and is Editor-in-Chief of npj: Primary Care Respiratory Medicine.
Aziz was made an Officer of the Order of the British Empire for Services to Medicine and Health Care by Her Majesty Queen Elizabeth II in 2014, and received a knighthood for services to COVID-19 research and policy in 2022.
Research summary
Aziz is a primary care academic and epidemiologist with substantial research interests in asthma/allergy and in leveraging the potential of health information technology and data science to transfrom the delivery of care and improve population health.
He enjoys collaborations with academic colleagues across the globe and works closely with policymakers both in the UK and internationally.
He has held research grants in excess of $90m, publishes regulalrly in the world's foremost journals, has over 50,000 citations to his work and is a Highly Cited Researcher (Clarivate, 2018).
Project activity
Aziz's projects include work on health inequalities and asthma.
-
Cost-utility of cytisine for smoking cessation over and above behavioural support in people with newly diagnosed pulmonary tuberculosis: an economic evaluation of a multicentre randomised controlled trial
In:
BMJ Open, vol. 12, pp. e049644
DOI: https://doi.org/10.1136/bmjopen-2021-049644
Research output: Contribution to Journal › Article (Published) -
Methodological issues for using a common data model (CDM) of COVID-19 vaccine uptake and important adverse events of interest (AEIs): the Data and Connectivity COVID-19 Vaccines Pharmacovigilance (DaC-VaP) United Kingdom feasibility study
In:
JMIR formative research, vol. 6, pp. e37821
DOI: https://doi.org/0.2196/37821
Research output: Contribution to Journal › Article (Published) -
Academic productivity of young people with allergic rhinitis: A MASK-air® study
In:
The Journal of Allergy and Clinical Immunology: In Practice
DOI: https://doi.org/10.1016/j.jaip.2022.08.015
Research output: Contribution to Journal › Article (E-pub ahead of print) -
Second-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
In:
Nature Communications, vol. 13, pp. 4800
DOI: https://doi.org/10.1038/s41467-022-32264-6
Research output: Contribution to Journal › Article (Published) -
Mixed-methods evaluation of a nurse-led allergy clinic model in primary care: Feasibility trial
In:
Clinical and translational allergy, vol. 12, pp. e12180
DOI: https://doi.org/10.1002/clt2.12180
Research output: Contribution to Journal › Article (Published) -
Vaccine effectiveness of two-dose BNT162b2 against symptomatic and severe COVID-19 among adolescents in Brazil and Scotland over time: a test-negative case-control study
In:
The Lancet Infectious Diseases
DOI: https://doi.org/10.1016/S1473-3099(22)00451-0
Research output: Contribution to Journal › Article (Published) -
The ARIA approach of Value-Added Medicines: as-needed treatment in allergic rhinitis
In:
The Journal of Allergy and Clinical Immunology: In Practice
DOI: https://doi.org/10.1016/j.jaip.2022.07.020
Research output: Contribution to Journal › Article (E-pub ahead of print) -
COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes from Delta AY.4.2: Cohort and test-negative study of 5.4 million individuals in Scotland
In:
Journal of Global Health, vol. 12, pp. 05025
DOI: https://doi.org/10.7189/jogh.12.05025
Research output: Contribution to Journal › Article (Published) -
Prevalence of sensitization to molecular food allergens in Europe: A systematic review
In:
Clinical and translational allergy, vol. 12, pp. e12175
DOI: https://doi.org/10.1002/clt2.12175
Research output: Contribution to Journal › Review article (E-pub ahead of print) -
Effect of comprehensive smoke-free legislation on neonatal mortality and infant mortality across 106 middle-income countries: a synthetic control study
In:
The Lancet Public Health, vol. 7, pp. e616-e625
DOI: https://doi.org/10.1016/S2468-2667(22)00112-8
Research output: Contribution to Journal › Article (Published)